13-AZAPROSTANOIC ACID - SPECIFIC ANTAGONIST OF THE HUMAN-BLOOD PLATELET THROMBOXANE-ENDOPEROXIDE RECEPTOR

被引：0
作者：
LEBRETON, GC
VENTON, DL
ENKE, SE
HALUSHKA, PV
机构：
[1] UNIV ILLINOIS,MED CTR,DEPT MED CHEM,CHICAGO,IL 60680
[2] MED UNIV S CAROLINA,DEPT MED,CHARLESTON,SC 29403
[3] MED UNIV S CAROLINA,DEPT PHARMACOL,CHARLESTON,SC 29403
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1979年 / 76卷 / 08期
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：4097 / 4101
页数：5
相关论文
共 50 条
[41]   CHARACTERIZATION OF THE INHIBITION OF U46619-MEDIATED HUMAN-PLATELET ACTIVATION BY THE TRIMETOQUINOL ISOMERS - EVIDENCE FOR ENDOPEROXIDE THROMBOXANE-A2 RECEPTOR BLOCKADE [J].
AHN, CH ;
ROMSTEDT, KJ ;
WALLACE, LJ ;
MILLER, DD ;
FELLER, DR .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (15) :3023-3033
[42]   HIGH-SENSITIVITY OF ARACHIDONIC ACID-INDUCED THROMBOXANE-A2 FORMATION IN HUMAN-BLOOD PLATELETS AGAINST INDOMETHACIN AND TIAPROFENIC ACID [J].
SCHROR, K ;
SAUERLAND, S ;
KUHN, A .
FEDERATION PROCEEDINGS, 1980, 39 (03) :531-531
[43]   Ligand-Specific Conformation Determines Agonist Activation and Antagonist Blockade in Purified Human Thromboxane A2 Receptor [J].
Ruan, Ke-He ;
Cervantes, Vanessa ;
Wu, Jiaxin .
BIOCHEMISTRY, 2009, 48 (14) :3157-3165
[44]   PURIFICATION OF THE HUMAN BLOOD-PLATELET THROMBOXANE-A2 PROSTAGLANDIN H2 RECEPTOR PROTEIN [J].
KIM, SO ;
LIM, CT ;
LAM, SCT ;
HALL, SE ;
KOMIOTIS, D ;
VENTON, DL ;
LEBRETON, GC .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (02) :313-322
[45]   ANTITHROMBOTIC EFFECTS OF RIDOGREL, A COMBINED THROMBOXANE-A2 SYNTHASE INHIBITOR AND PROSTAGLANDIN ENDOPEROXIDE-RECEPTOR ANTAGONIST, IN A PLATELET-MEDIATED CORONARY-ARTERY OCCLUSION PREPARATION IN THE DOG [J].
YASUDA, T ;
GOLD, HK ;
YAOTIA, H ;
GUERRERO, JL ;
HOLT, RE ;
FALLON, JT ;
LEINBACH, RC ;
COLLEN, D .
CORONARY ARTERY DISEASE, 1991, 2 (10) :1103-1110
[46]   STIMULATION OF LEUKOTRIENE BIOSYNTHESIS IN HUMAN-BLOOD LEUKOCYTES BY PLATELET-DERIVED 12-HYDROPEROXY-ICOSATETRAENOIC ACID [J].
MACLOUF, J ;
DELACLOS, BF ;
BORGEAT, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (19) :6042-6046
[47]   ARACHIDONIC-ACID METABOLITES PRODUCED BY PLATELET-DEPLETED HUMAN-BLOOD MONOCYTES - A POSSIBLE ROLE IN THROMBOGENESIS [J].
JONES, CM ;
HALL, ER ;
HESTER, JP ;
WU, KK .
AMERICAN JOURNAL OF HEMATOLOGY, 1989, 31 (03) :145-152
[48]   THE EFFECT OF THE THROMBOXANE A2 PROSTAGLANDIN ENDOPEROXIDE RECEPTOR ANTAGONIST SQ 30,741 ON MYOCARDIAL INFARCT SIZE AND BLOOD-FLOW DURING MYOCARDIAL ISCHEMIA AND REPERFUSION [J].
GROVER, GJ ;
SCHUMACHER, WA ;
SIMON, M ;
PARHAM, C .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 (06) :701-709
[49]   EFFECTS OF SQ-27,427, A THROMBOXANE-A2 RECEPTOR ANTAGONIST, IN THE HUMAN-PLATELET AND ISOLATED SMOOTH-MUSCLE [J].
HARRIS, DN ;
GREENBERG, R ;
PHILLIPS, MB ;
MICHEL, IM ;
GOLDENBERG, HJ ;
HASLANGER, MF ;
STEINBACHER, TE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 103 (1-2) :9-18
[50]   The AT1 receptor antagonist irbesartan inhibits thromboxane A2-induced human platelet aggregation and vasoconstriction in canine coronary arteries [J].
Li, P ;
Fukuhara, M ;
Diz, DI ;
Ferrario, CM ;
Brosnihan, KB .
CIRCULATION, 1999, 100 (18) :808-808
12345